Characterization of variable systemic and mucosal immunity during SARS-CoV-2 infection and recovery

COVar_Immune project

AimOur knowledge of the kinetics, intensity and diversity of cellular and humoral immune responses following SARS-CoV-2 infection in humans is limited. Using a novel technical pipeline based on the Milieu Interieur cohort approach, we will characterize systemic as well as local mucosal immunity during and after SARS-CoV-2 infection. We aim to identify immune signatures that can distinguish clinical outcomes (recovery versus virus-induced pathologies).

Back to top